The Potassium Supplementation Study

NCT ID: NCT05887622

Last Updated: 2025-06-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-24

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will test whether potassium supplementation can reduce the deleterious effect of a high sodium diet on blood vessel function, blood pressure reactivity and autonomic nervous system function in apparently healthy adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Excess sodium intake is linked to poor blood pressure (BP) regulation and endothelial dysfunction, both of which are implicated in the pathogenesis of atherosclerosis and high BP. Evidence suggests potassium may offset the damaging effects of sodium; however, studies in healthy adults are lacking. This is important as these pre-clinical risk factors have been observed in this population, suggesting early intervention may be critical for cardiovascular disease prevention. High potassium diets have been effective at attenuating a sodium-induced decline in endothelial function. However, potassium intake was increased using whole foods; thus, the vascular benefits cannot be attributed solely to potassium. Furthermore, whether potassium can reduce sodium-induced oxidative stress is unknown. The central hypothesis of this study is that endothelial function will be greater and BP reactivity and oxidative stress will be lower with a high potassium intake compared to a low potassium intake, in the context of a high sodium diet. The investigators will assess macrovascular function using flow-mediated dilation, BP reactivity using the cold pressor test and isometric handgrip grip test, and oxidative stress using electron paramagnetic resonance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Health Cardiovascular Risk Factor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

All participants will complete all arms in a randomized, crossover design.
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants
Participants will be blinded to the diet they are on.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Moderate potassium/low sodium

Subjects will consume a diet moderation in potassium and low in sodium.

Group Type EXPERIMENTAL

Placebo

Intervention Type DIETARY_SUPPLEMENT

Subjects will receive a placebo capsule on the moderate potassium/low sodium diet and the moderate potassium/high sodium diet

Moderate potassium/high sodium

Subjects will consume a diet moderation in potassium and high in sodium.

Group Type EXPERIMENTAL

Placebo

Intervention Type DIETARY_SUPPLEMENT

Subjects will receive a placebo capsule on the moderate potassium/low sodium diet and the moderate potassium/high sodium diet

High potassium/high sodium

Subjects will consume a diet moderation in potassium and high in sodium.

Group Type EXPERIMENTAL

Potassium chloride supplement

Intervention Type DIETARY_SUPPLEMENT

Subjects will receive 64 mmol of KCl on the high potassium/high sodium condition.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Potassium chloride supplement

Subjects will receive 64 mmol of KCl on the high potassium/high sodium condition.

Intervention Type DIETARY_SUPPLEMENT

Placebo

Subjects will receive a placebo capsule on the moderate potassium/low sodium diet and the moderate potassium/high sodium diet

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* men and women
* 18-45 years of age
* all races/ethnicities
* BMI \< 30 kg/m2
* BP \< 130/80 mmHg

Exclusion Criteria

* presence of hypertension
* known heart disease
* diabetes
* kidney disease
* cancer
* inflammatory conditions
* blood clotting disorders
* pregnancy
* adrenal gland disorder
* history of stomach or intestinal bleeding
* history of kidney stones
* serum potassium outside of the normal range
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Delaware

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shannon Lennon

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tower at STAR

Newark, Delaware, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Shannon L Lennon, PhD

Role: CONTACT

3023824291

Cesar J Jacintho Mortiz, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Shannon J Lennon

Role: primary

Cesar L Jacintho Mortiz

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1465208

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dietary Salt Intake and Vascular Function
NCT00590512 COMPLETED EARLY_PHASE1
Potassium Supplementation in CKD
NCT03253172 ACTIVE_NOT_RECRUITING NA
China Salt Substitute Study
NCT00145756 COMPLETED NA